C-反应蛋白\补体C3与冠脉慢血流关系研究(2)
 |
| 第1页 |
参见附件(1435KB，2页)。
[参考文献]
[1]Tambe AA, Demany MA, Henry A, et al. Angian pectoris and slow flow velocity of dye in coronary arteries:a new angiographic finding [J]. Am Heart J,1972,84(1):66-71.
[2]Goel PK, Gupta SK, Agarwal A, et al. Slow coronary flow: a distinct angiographic subgroup in syndrome X [J]. Angiology,2001,52(8):507-514.
[3]Mangieri E, Macchiarelli, Ciavolella M, et al. Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries [J]. Cathet Cardiovasc Diang,1996,37(4):375-381.
[4]Burchartt BA, Mukeriji V, Alpert MA, et al. Coronary artery slow flow associated with angina pectoris and hypertension:a case repot [J]. Angiology,1998,49(6):483-487.
[5]Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow [J]. Circulation,1996,93:879-888.
[6]Li JJ, Fang CH. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular disease [J]. Med Hypothe,2004,62(4):499-506.
[7]李志强,郑兴.炎症与冠心病[J].中国心血管病研究,2006,4(3):233-235.
[8]Li JJ, Fang CH. Atheroscleritis is a more rational term for the pathological entity currently known as atherosclerosis [J]. Med Hypothe,2004,63(1):100-102.
[9]Li JJ. Inflammation is an important mechanism for different clinical entities of coronary artery disease [J]. Clin Med J,2005,118(21):761-768.
[10]Turhan H, Saydam GS, Erbay AR, et al. Increased plasma soluble adhesion molecules ICAM-1,VCAM-1, and E-selection levels in patients with slow coronary flow [J]. Int J Cardiol,2006,108(2):224-230.
[11]Cliskan M, Erdogan D, Gullu H, et al. Effects of atorvastatin on coronary flow reserve in patients with slow coronary flow [J]. Clin Cardiol,2007,30(9):475-479.
[12]Cakmak M, Tanriverdi H, Cakmak N, et al. Simvastatin may improve myocardial perfusion abnormality in slow coronary flow[J]. Cardiology, 2008,110(1):39-44.
(收稿日期：2010-06-16)
您现在查看是摘要介绍页，详见PDF附件(1435KB，2页)。